AI-generated summary
The authors studied photobiomodulation therapy using a 660 nm laser at four radiant energy doses in mice with chronic ovalbumin-induced asthma. They report reduced airway inflammation, lower pro-inflammatory cytokines, higher anti-inflammatory IL-10, more regulatory T cells, and less mucus and collagen, with the strongest effects at 3 and 5 J.
- Who or what was studied
- Mice with chronic allergic asthma induced by ovalbumin (experimental murine model)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study is in an experimental mouse model, so the findings may not apply to humans, and the abstract does not report a total sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Total energy
- 7.5 J, 5 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Inflammation, Photobiomodulation, Collagen, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.